This trial is testing a new drug for people with myelodysplastic/myeloproliferative neoplasms or chronic neutrophilic leukemia. They want to see if it's effective, safe, and tolerated.
- Myeloproliferative Neoplasms
- Chronic Neutrophilic Leukemia
- Myelodysplastic Syndrome
1 Primary · 4 Secondary · Reporting Duration: at week 24
Awards & Highlights
1 Treatment Group
Treatment with Fedratinib
1 of 1
25 Total Participants · 1 Treatment Group
Primary Treatment: Fedratinib Pill · No Placebo Group · Phase 2
Who is running the clinical trial?
Age 18+ · All Participants · 0 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are there other ongoing trials that are testing fedratinib?
"There are a total of 9 clinical trials underway that focus on Fedratinib Pill. 2 of those studies have progressed to Phase 3. Even though most research is based in Hackensack, New Jersey, there are actually 284 trial locations across the globe." - Anonymous Online Contributor
What are the potential side effects of Fedratinib?
"While Phase 2 trials don't provide efficacy data, Fedratinib Pill's safety was supported enough to give it a score of 2." - Anonymous Online Contributor
What is the usual indication for Fedratinib?
"Fedratinib Pill can help patients in intermediate-2 ipss risk categories, high ipss risk categories, and those suffering from secondary myelofibrosis." - Anonymous Online Contributor
How many people are currently involved in this research project?
"The information available on clinicaltrials.gov suggests that this research is still recruiting patients. The trial was first posted on March 1st, 2022 and the most recent update was on November 1st, 2022. They are hoping to enroll 25 individuals at a single site." - Anonymous Online Contributor
Are there any current openings for subjects in this experiment?
"That is accurate, the clinical trial indicated on clinicaltrials.gov is actively recruiting patients. The listing was first posted on March 1st, 2022 and was last updated on November 1st, 2022. They are looking for a total of 25 individuals to participate across one location." - Anonymous Online Contributor
Have there been any other similar clinical trials to this one in the past?
"Nine clinical trials using the Fedratinib Pill are ongoing in 20 countries and 49 cities. The first trial was completed in 2019 by Impact Biomedicines, Inc., a subsidiary of Celgene Corporation. This Phase 3 drug approval process included 38 patients. Since then, 15 more trials have been carried out." - Anonymous Online Contributor